MacKenzie B.; Korfei M.; Henneke I.; Sibinska Z.; Tian X.; Hezel S.; Dilai S.; Wasnick R.; Schneider B.; Wilhelm J.; El Agha E.; Klepetko W.; Seeger W.; Schermuly R.; Günther A.; Bellusci S.
(2015)
© 2015 MacKenzie et al. Background: Recent clinical studies show that tyrosine kinase inhibitors slow the rate of lung function decline and decrease the number of acute exacerbations in patients with Idiopathic Pulmonary ...